Rugtveit J, Haraldsen G, Høgåsen A K, Bakka A, Brandtzaeg P, Scott H
Laboratory for Immunohistochemistry and Immunopathology (LIIPAT), Institute of Pathology, Oslo, Norway.
Gut. 1995 Sep;37(3):367-73. doi: 10.1136/gut.37.3.367.
Macrophages play a crucial role in intestinal mucosal defence, forming dense subepithelial aggregates, particularly in the colon. One of their important bactericidal mechanisms is production of oxygen radicals but this may damage the intestinal epithelium, perhaps as an early step in inflammatory bowel disease (IBD). The potential for release of oxygen radicals from mucosal macrophages in IBD was measured and whether a difference exists between newly arrived (CD14+L1+) monocyte-like cells and resident macrophages (CD14(-)L1-), without or with additional priming in vitro, was investigated. Lamina propria mononuclear cells from six patients with IBD and five with a normal intestine were isolated with an ethylenediaminetetra acetic acid/collagenase/dispase technique and cultured for three days. The cells were tested with or without interferon gamma (200 U/ml) priming in the presence or absence of lipopolysaccharide (1 microgram/ml) for the last 48 hours in cultures. Samples from inflamed IBD mucosa depleted of CD14+ cells by immunomagnetic beads were compared with their undepleted counterparts and with samples from virtually normal mucosa from the same patients. The production of oxygen radicals was measured as the amount of reduced cytochrome C 2.5 hours after triggering with phorbol 12-myristate 13-acetate. The oxygen radical production in macrophages from moderately or severely inflamed mucosa was reduced by median 69% (range 22%-79%, p < 0.027) after depletion of CD14+ cells, reaching a level similar to that found for virtually normal samples from the same IBD patients. Furthermore, this production did not increase significantly in mucosal macrophages from normal reference mucosa and from virtually normal or inflamed IBD mucosa after priming with interferon gamma with or without addition of lipopolysaccharide. Upregulation of a respiratory burst in subepithelial resident macrophages os not a likely pathogenetic step in IBD. The increased oxygen radical production shown by macrophages from IBD lesions can, however, be ascribed to recently extravasated CD14+L1+ monocyte-like cells. Inhibition of extravasation of these reactive cells may form part of a therapeutic approach in the future.
巨噬细胞在肠道黏膜防御中发挥关键作用,在结肠等部位形成密集的上皮下聚集物。其重要的杀菌机制之一是产生氧自由基,但这可能会损伤肠道上皮,这或许是炎症性肠病(IBD)的早期步骤。本研究测量了IBD中黏膜巨噬细胞释放氧自由基的潜力,并探究了新到达的(CD14+L1+)单核细胞样细胞与驻留巨噬细胞(CD14(-)L1-)之间是否存在差异,以及在体外有无额外刺激的情况下这种差异是否存在。采用乙二胺四乙酸/胶原酶/分散酶技术从6例IBD患者和5例肠道正常者的固有层单核细胞中分离细胞,并培养3天。在培养的最后48小时,对细胞进行有或无干扰素γ(200 U/ml)刺激、有或无脂多糖(1μg/ml)存在的测试。通过免疫磁珠去除CD14+细胞的IBD炎症黏膜样本与其未去除的对应样本以及同一患者的几乎正常黏膜样本进行比较。在用佛波醇12 -肉豆蔻酸酯13 -乙酸酯触发2.5小时后,以细胞色素C还原量来测量氧自由基的产生。去除CD14+细胞后,中度或重度炎症黏膜中巨噬细胞的氧自由基产生量中位数降低了69%(范围为22% - 79%,p < 0.027),达到与同一IBD患者几乎正常样本相似的水平。此外,在有或无脂多糖添加的情况下,用干扰素γ刺激后,正常对照黏膜以及几乎正常或炎症性IBD黏膜中的黏膜巨噬细胞的这种产生量并未显著增加。上皮下驻留巨噬细胞呼吸爆发的上调不太可能是IBD发病机制中的一个步骤。然而,IBD病变部位巨噬细胞显示出的氧自由基产生增加可归因于最近渗出的CD14+L1+单核细胞样细胞。抑制这些反应性细胞的渗出可能成为未来治疗方法的一部分。